CNXC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Concentrix Corp (CNXC) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown some positive revenue growth and cost-saving measures, the significant drop in net income, EPS, and negative market sentiment outweigh the positives. The technical indicators and options data suggest bearish sentiment, and there are no strong proprietary trading signals to support an immediate buy decision.
The technical indicators for CNXC are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 40.277, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 25.796 and resistance at 33.222.
The company reported a 5.4% YoY revenue increase in Q1 2026 to $2.5 billion. It also announced cost-saving measures expected to generate $40 million annually. Additionally, the company continues to focus on AI-driven innovations, such as the iX Hello platform, which could drive future growth.
The operating margin also declined to 4.7%. Analysts have lowered price targets significantly, citing execution risks and deceleration in growth. The stock has experienced a sharp sell-off, with a 22% drop following Q1 results. Options data indicates bearish sentiment with a high put-call ratio.
In Q1 2026, Concentrix reported a 5.4% YoY revenue increase to $2.5 billion. However, net income dropped by 67.7% YoY to $21.59 million, and EPS declined by 66.35% YoY to $0.35. Gross margin improved by 7.43% YoY to 33.98%. Despite revenue growth, the significant decline in profitability raises concerns.
Analysts have lowered their price targets significantly: Barrington to $38 (from $62), Baird to $40 (from $52), and Canaccord to $55 (from $80). All maintain positive ratings (Outperform or Buy), but they cite execution risks, deceleration in growth, and disproportionate market reactions as concerns.
